Skip to main content
padlock icon - secure page this page is secure

Review. The role of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective

Buy Article:

$38.00 + tax (Refund Policy)

The angiogenic growth factor thymidine phosphorylase/PD-ECGF has been identified as a potential target in the development of anti-cancer drugs. This review firstly discusses the biological role of TP/PD-ECGF and its importance in the activation of 5-fluorouracil and its prodrugs. The chemistry and chemotherapeutic potential of TP/PD-ECGF inhibitors are also discussed.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 5-fluorouracil; PD-ECGF; TP inhibitors; angiogenesis; anti-cancer drugs; thymidine phosphorylase

Document Type: Research Article

Affiliations: Corresponding author

Publication date: October 1, 1999

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more